To address the significance of BAG-1 as a biomarker in breast cancer, we have performed a systematic review against the REporting Recommendations for Tumour MARKer and Prognostic Studies (REMARK) criteria (McShane et al, 2005), which provide a framework for reporting of studies of cancer biomarkers. This evidence concerns the gene BAG1 and breast cancer.